The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up...
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
We have previously reported that genetically positive patients have a more profound early decrease in provocable left ventricular outflow tract gradient compared to genetically negative patients utilizing mavacamten in the first 12 weeks of therapy.
In this current analysis, we found that genetically positive patients have less favorable remodel...
Alternative Titles
Full title
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3101794200
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3101794200
Other Identifiers
ISSN
0002-8703,1097-6744
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2024.07.001
